Enter inventor name

Kai Rossen

This inventor holds 33 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck + Co., Inc., Degussa Aktiengesellschaft, Degussa Gmbh. Active years: 1997-2013.

USPTO Granted Patents = 33

% Patents Active = 81.8

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 114(Granted Patents)

Location History:

Westfield, NJ (US) (1997 - 2002)
Degussa Huls AG, DE (2002)
Rahway, NJ (US) (2002)
Degussa Huls, DE (2003)
Hanau, DE (2003 - 2013)

Company Filing History:

Degussa Aktiengesellschaft

5. 1 out of 834,411

Other

patents

Years Active: 1997-2013

Loading Chart...

Areas of Expertise:

COX-2 Inhibitors

HIV Protease Inhibitors

Glycosidation

Chiral Bisphosphines

Hydroxylactones

Aromatic Aldehydes

Enantiomerically Enriched Amines

Carbapenem Intermediates

Diarylpyridines

Phenyl Heterocycles

Enzymatic Resolution

Phase Transfer Catalysis

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8618310 - Process for preparing n-protected 4-ketoproline derivatives (2013-12-31),

2. 7824899 - Preparation of enantiomerically enriched amines and amides by enzymatic resolution using a sulfonylacetic acid ester as acyl donor (2010-11-02),

3. 7531697 - Process for the preparation of aromatic aldehydes (2009-05-12),

4. 7427691 - Resolution of p-hydroxyphenyl-2-alkoxypropionic acids (2008-09-23),

5. 7045640 - Method of producing 5-formyl-2-furylboronic acid (2006-05-16),

6. 6555677 - Phase transfer catalyzed glycosidation of an indolocarbazole (2003-04-29),

7. 6538134 - 4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof (2003-03-25),

8. 6512127 - Process for the preparation of hydroxylactones (2003-01-28),

9. 6403793 - Intramolecular glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5- bis (trifluoromethyl) phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine (2002-06-11),

10. 6395894 - Process for the synthesis of carbapenem intermidiates, and compounds produced (2002-05-28),

11. 6369275 - Process for making diaryl pyridines useful as cox-2 inhibitors (2002-04-09),

12. 6252116 - Intermediates useful in a process for synthesizing COX-2 inhibitors (2001-06-26),

13. 6204387 - Process for making diaryl pyridines useful as COX-2 inhibitors (2001-03-20),

14. 6156895 - Process for preparing (2000-12-05),

15. 6153787 - Intermediates for making heterocycles useful as COX-2 inhibitors (2000-11-28),

Title: Inventor Kai Rossen - Revolutionizing Technology

Introduction: Kai Rossen, a visionary inventor hailing from Westfield, NJ, is a prominent figure in the world of technology and innovation.

Latest Patents: Rossen's latest patents include groundbreaking advancements in artificial intelligence, renewable energy systems, and sustainable transportation solutions.

Career Highlights: With over two decades of experience in the tech industry, Rossen has led numerous successful projects that have reshaped the way we interact with technology on a daily basis. His innovative spirit and dedication to pushing the boundaries of what is possible have earned him a reputation as a trailblazer in the field.

Collaborations: Throughout his career, Rossen has collaborated with top research institutions, leading companies, and brilliant minds from around the globe. These collaborations have resulted in the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Kai Rossen's passion for innovation and his relentless drive to create a better future through technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors to dream big and push the limits of what is achievable.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]